对"加拿大人需要更好地获得治疗罕见疾病的药物,而不是更多的拒绝"的回应
HealthcarePapers
|July 7, 2023
概括
加拿大药品价格上并没有改善人们获得罕见疾病治疗的机会. 患有罕见疾病的患者应该得到公平的医疗保健,并且必须通过更好的解决方案来解决未满足的需求.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 罕见疾病 罕见疾病
背景情况:
- 在全球范围内,患者获得罕见疾病治疗方法仍然是一个重大挑战.
- 罕见病患者的观点突出了医疗保健的关键未满足需求.
- 关于药品定价政策对治疗可及性的影响存在争论.
研究的目的:
- 为了解决罗森和亚当斯 (2023) 关于加拿大罕见病药物获取的评论.
- 挑战加拿大药品价格上改善了对罕见疾病治疗的机会的说法.
- 倡导寻求替代解决方案,以提高罕见病患者获得医疗保健的机会.
主要方法:
- 罗森和亚当斯 (2023) 对评论的批判分析.
- 对现有的关于罕见病治疗准入和药物定价的文献进行审查.
- 基于医疗保健公平的既定原则的论证性回应.
主要成果:
- 加拿大更高的药物价格将解决罕见疾病治疗的获取问题这一论点受到质疑.
- 在医疗保健讨论中,患者视角的关键重要性得到了承认.
- 对于患有罕见疾病的患者来说,仍然存在大量未满足的需求.
结论:
- 在加拿大维持更高的药物价格不是改善获得罕见疾病治疗的可行策略.
- 为所有患者,包括那些患有罕见疾病的患者,提供公平的医疗保健服务至关重要.
- 需要进一步探索有效的策略,以解决罕见疾病人群中未满足的需求.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
780
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
780
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Factors Affecting Drug Distribution: Physiological Barriers
257
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
257
Drug Control Governance: Regulatory Bodies and Their Impact
190
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
190
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Pharmacovigilance
903
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
903


